Publication | Open Access

Clinicopathologic Features and Immune Microenvironment of Non–Small-cell Lung Cancer With Primary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Non–small-cell Lung CancerCancer ImmunosurveillanceImmune MicroenvironmentMedicineImmunologyTumor ImmunityPathologyPrimary ResistanceImmune SurveillanceImmune Checkpoint InhibitorCancer BiologyLung CancerOncologyCancer GrowthTumor MicroenvironmentTumor Biology